CORT vs MKC · P/E 199, rev $675.0M vs P/E 8.4, $13.56B cap
Corcept Therapeutics Incorporated (CORT) versus McCormick & Company Incorporated (MKC) — a side-by-side from cached financials, not a winner call.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
McCormick & Company Incorporated (MKC) is a packaged foods company listed on US.
Latest reported CORT revenue for 2024-12-31 was $675.0M. Net income was $141.2M. Revenue was up 39.9% from 2023-12-31 to 2024-12-31. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
MKC does not have a complete income-statement cache yet.
CORT currently screens at market cap $7.46B and trailing P/E 198.5. MKC currently screens at market cap $13.56B and trailing P/E 8.4.
Not investment advice. Open the CORT and MKC stock pages for the full models.
Not investment advice.